March 13 (Reuters) - MeiraGTx Holdings PLC MGTX.O:
MEIRAGTX ENTERS INTO A STRATEGIC COLLABORATION WITH HOLOGEN AI TO EXPEDITE PHASE 3 DEVELOPMENT OF AAV-GAD FOR PARKINSON’S DISEASE AND INDUSTRIALIZE MEIRAGTX’S PROPRIETARY MANUFACTURING PROCESS
MEIRAGTX HOLDINGS PLC - TO RECEIVE $200 MILLION IN UPFRONT CASH
MEIRAGTX HOLDINGS PLC - TO RETAIN 30% OWNERSHIP IN JOINT VENTURE
MEIRAGTX HOLDINGS PLC - JOINT VENTURE HOLOGEN NEURO AI LTD TO RECEIVE $230 MILLION
Source text: ID:nGNX88BhqQ
Further company coverage: MGTX.O
((Reuters.Briefs@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。